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INTRODUCTION
Liver abscess, particularly due to amebiasis, is an important 
clinical problem in tropical regions of  the world and 
accounts for a high number of  hospital admissions[1-5]. It 
is usually an easily treatable condition with good clinical 
outcomes. There is however potential for morbidity and 
even mortality if  proper and timely treatment is not 
provided[6-9]. The standard treatment of  liver abscess is the 
use of  appropriate antibiotics and supportive care. Needle 
aspiration can be used as an additional mode of  therapy 
and has been promoted by some authors for routine use 
in the treatment of  uncomplicated liver abscess. It is 
suggested that needle aspiration can improve response 
to antibiotic treatment, reduce hospital stay and the 
total cost of  treatment[10-12]. Although ultrasound guided 
needle aspiration is fairly safe, it is nonetheless an invasive 
procedure requiring the passage of  a wide bore needle into 
a highly vascular organ, and can be associated with the risk 
of  bleeding. Needle aspirations, especially at the time of  
intervention has therefore remained a debatable issue and 
it seems important to determine its possible role in the 
treatment of  liver abscess[13-16].
We have used a large database of  patients admitted to 
hospital with liver abscess in order to determine the factors 
associated with the likelihood of  liver abscess aspiration in 
the treatment of  patients with uncomplicated liver abscess.
MATERIALS AND METHODS
Medical records of  all patients admitted to our hospital 
with liver abscess over a ten-year period (Jan. 1995 to Dec. 
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Abstract
AIM: To determine the predictive factors for early 
aspiration in liver abscess.
METHODS: A retrospective analysis of all patients with 
liver abscess from 1995 to 2004 was performed. Abscess 
was diagnosed as amebic in 661 (68%) patients, 
pyogenic in 200 (21%), indeterminate in 73 (8%) and 
mixed in 32 (3%). Multiple logistic regression analysis 
was performed to determine predictive factors for 
aspiration of liver abscess. 
RESULTS: A total of 966 patients, 738 (76%) male, 
mean age 43 ± 17 years, were evaluated: 540 patients 
responded to medica l therapy whi le adjunct ive 
percutaneous aspiration was performed in 426 patients. 
Predictive factors for aspiration of liver abscess were: 
age ≥ 55 years, size of abscess ≥ 5 cm, involvement of 
both lobes of the liver and duration of symptoms ≥ 7 d. 
Hospital stay in the aspiration group was relatively longer 
than in the non aspiration group. Twelve patients died in 
the aspiration group and this mortality was not statistically 
significant when compared to the non aspiration group. 
CONCLUSION: Patients with advanced age, abscess 
size > 5 cm, both lobes of the liver involvement and 
duration of symptoms > 7 d were likely to undergo 
aspiration of the liver abscess, regardless of etiology.  
© 2008 WJG. All rights reserved.
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2004) were identified using the International classification 
of  diseases 9th revision with clinical modification (ICD-
9-CM-USA) and reviewed retrospectively. Patients with 
complicated liver abscess, generally due to rupture of  
abscess, were excluded from this analysis, as the indications 
for needle aspiration in these patients are rather different 
(Figure 1). Diagnosis of  liver abscess was based upon 
clinical history and abdominal ultrasound or CT scan 
findings. The following data was collected in all the patients 
who were diagnosed with uncomplicated liver abscess: 
demographic information, chief  complaint, duration of  
fever or abdominal pain, associated illnesses, malignancy 
and history of  biliary surgery or other procedures. Results 
of  laboratory investigations and imaging studies done at 
the time of  admission were recorded as were the clinical 
course of  disease, modalities of  treatments used and 
outcome of  the patients.
Patients with uncomplicated (non-ruptured) liver 
abscess were underwent to the following investigations: 
Complete blood counts, imaging by ultrasound, Indirect 
Hem-agglutination Assay (IHA) for amebiasis, blood 
culture and pus culture if  the abscess was aspirated. IHA 
was done with serology reagent “Cellognost Amebiasis” 
supplied by (Dade Behring Marburg GmbH Germany) and 
a titer of  ≥ 1:128 was taken as diagnostic for amebic liver 
abscess, as per the manufacturer’s recommendations. Based 
upon the results of  these investigations, patients with 
liver abscess were categorized into four groups according 
to the following criteria: (1) Amebic liver abscess (ALA): 
IHA titer ≥ 1:128 with negative blood or pus culture. (2) 
Pyogenic liver abscess (PLA): IHA titer < 1:32 with or 
without positive blood and/or pus culture. (3) Mixed liver 
abscess (MLA): IHA titer ≥ 1:128 with positive blood 
and/or pus culture and (4) Indeterminate liver abscess 
(ILA): IHA titer between 1:32 and 1:128 with negative 
blood or pus culture. According to our usual practice, 
patients were started on standard treatment of  liver 
abscess and if  no clinical response was observed within 
three days, therapeutic percutaneous needle aspiration 
was carried out at the discretion of  the treating physician. 
Needle aspiration was done under local anesthesia and 
ultrasound guidance without catheter drainage and the 
procedure was repeated in 3-4 d if  optimal response was 
not obtained. Antibiotics were continued for 10-14 d for 
ALA, 4-6 wk for PLA and mixed infection and 2-6 weeks 
for indeterminate abscess. 
Statistical analysis
A descriptive analysis was done for demographic, clinical 
and radiographic features and results were presented 
as mean ± SD for quantitative variables and number 
(percentage) for qualitative variables. In univariate analyses, 
differences in proportions for the group of  patient 
underwent to needle aspiration and no aspiration was done 
by using the Chi-square test or Fisher exact test where 
appropriate. One-way analysis of  variance and independent 
samples t-test were used to assess the difference of  means 
for contrasts of  continuous variables. Multiple logistic 
regression analysis was done and factors associated with 
likelihood of  abscess aspiration were identified.
RESULTS
A total of  1020 patients with liver abscess were admitted 
during the study per iod. Fifty four pat ients with 
complicated liver abscess were excluded from the study 
and 966 patients with uncomplicated liver abscess were 
evaluated (Figure 1). The mean age was 43 ± 17 years 
and 738 (76%) were males. The abscess was diagnosed as 
amebic (ALA) in 661 (68%), pyogenic (PLA) in 200 (21%), 
indeterminate (ILA) in 73 (8%) and mixed (MLA) in 32 
(3%) patients. Clinical features of  the patients in different 
types of  liver abscess are presented in Table 1. Five 
hundred and forty patients responded to medical therapy 
alone; adjunctive percutaneous aspiration was performed 
in 426 patients. Demographic, clinical and laboratory 
features of  the two groups are compared in Tables 2-4. 
There were significant differences between aspiration and 
non aspiration groups for many covariates.
In the aspiration group, more patients were older 
than 55 years (OR = 1.008; 95% CI = 1.0-1.01), duration 
of  symptoms was more than 7 d (OR=1.60; 95% CI = 
1.21-2.11), they were more likely to be jaundiced (OR = 
1.55; 95% CI = 1.18-2.17), have tender hepatomegaly (OR 
= 0.68; 95% CI = 0.48-0.97) and hospital stay of  more 
than 5 d (OR = 2.99; 95% CI = 1.75-2.99), as compared to 
the non-aspiration group (Table 2).
In the laboratory features the meaningful predictors of  
aspiration were elevated total bilirubin (OR = 1.09; 95% 
CI = 1.04-1.15), ALT (OR = 1.002; 95% CI = 1.0-1.004), 
alkaline phosphatase (OR = 1.002; 95% CI = 1.001-1.003), 
total leukocyte count (OR = 1.01; 95% CI = 1.004-1.03) 
and platelet count (OR = 1.001; 95% CI = 1.0-1.002), 
whereas relatively low serum albumin (OR = 0.59; 95% 
CI = 0.44-0.80) was found in the aspiration group as 
compared to the non aspiration group (Table 3).
The aspiration group, when compared with the non-
aspiration group, was also found to have more patients 
with abscess sizes larger than 5 cm (OR = 1.59; 95% CI 
= 1.21-2.09), multiple abscesses (OR = 1.66; 95% CI = 
1.23-2.24), involvement of  both lobes of  the liver (OR = 
Total patients with liver abscess (1020)
Uncomplicated liver abscess cases (966)
Pyogenic liver abscess (200)
Complicated cases excluded (54)
Indeterminate liver abscess (73)
Amebic liver abscess (661) Mixed liver abscess (32)
Aspiration done (426) Medical therapy only (540)
Uncomplicated liver abscess cases (966)
Figure 1  Flow diagram of the patients with liver abscess and treatment received.
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1.92; 95% CI = 1.15-3.18) and abnormal chest X-rays (OR 
= 1.31; 95% CI = 1.01-1.70) (Table 4).
Using multiple logistic regression, independent predictors 
for aspiration of  liver abscess were age > 55 years, (OR = 1.6; 
95% CI = 1.2-2.2), size of  abscess more than 5 cm (OR = 1.6, 
95% CI = 1.2-2.09), both lobes of  the liver involvement (OR 
= 2.2, 95% CI = 1.5-3.4) and duration of  symptoms lasting 
more than seven days (OR = 1.6, 95% CI = 1.2-2.1) (Table 5).
The number of  abscesses ranged from 1-6 (median 2). 
None of  the patients with uncomplicated liver abscess 
required surgery. In 403 (42%) patients, only one aspiration 
session was done and in 23 (2%) patients, 2-3 aspiration 
sessions were done before full recovery.
Twelve patients died in the aspiration group, although 
this mortality was not statistically significant when compared 
with the non aspiration group (Table 2). No deaths occurred 
as a direct complication of  the needle aspiration. 
DISCUSSION
The use of  needle aspiration in the treatment of  uncompli-
cated liver abscess remains a debatable issue. Although 
Characteristics Aspiration
group
(n  = 426) 
Non 
aspiration
group
(n = 540)
Odds 
ratio
95% CI P
value
Gender
   Male 365 (85.7) 454 (84.1) 1.13 0.79-1.61 0.490
   Female   61 (14.3)   86 (15.9) 1.00
Age
   < 55 yr 282 (66.0) 412 (76.0) 1.00 1.2-2.2 0.001
   ≥ 55 yr  144 (34.0)a 128 (24.0) 1.60
Duration of symptoms1 (n%)
   < 7 d  111(26.1) 195 (36.1) 1.00
   ≥ 7 d  315 (73.9)a 345 (63.9) 1.60 1.21-2.11 0.001
Jaundice (n%)
   Yes    91 (21.4)a   80 (14.8) 1.55 1.18-2.17 0.009
   No 335 (78.6) 459 (85.2) 1.00
Diabetes mellitus (n%)
   Yes   70 (16.4)   99 (18.3) 0.87 0.62-1.22 0.440
   No 356 (83.6) 441 (81.7) 1.00
Patient outcome (n%)
   Alive 414 (97.2) 530 (98.1) 1.00 0.65-3.59 0.320
   Died 12 (2.8) 10 (1.9) 1.53
Hospital stay (n%)
   < 5 d 126 (29.6) 265 (49.1) 1.00
   ≥ 5 d  300 (70.4)a 275 (50.9) 2.29 1.75-2.99 0.001
Table 2  Clinical features of patients with liver abscess
Variable compared to reference category (OR = 1), aP < 0.05; 1Fever or 
abdominal pain.
Table 1  Clinical features of the patients with different types of 
liver abscess  n  (%)
Characteristics Amebic Pyogenic Mixed Indeterminate P
abscess abscess abscess abscess value
(n  = 661) (n  = 200) (n  = 32) (n  = 73)
Gender 
   Male 568 (86) 158 (79) 27 (84) 66 (90) 0.06
   Female   93 (14)   42 (21)   5 (16)   7 (10)
Age 
   < 55 yr 471 (71) 146 (73) 25 (78) 52 (71)
   ≥ 55 yr 190 (29)   54 (27)   7 (22) 21 (29) 0.83
Duration of symptoms1
   ≥ 7 d 453 (69) 136 (68) 24 (75) 47 (64) 0.752
   < 7 d 208 (32)   64 (32) 8 (25) 26 (36)
Jaundice (%)
   No 534 (81) 170 (85) 26 (81) 64 (88)
   Yes 126 (19)   30 (15)   6 (19)   9 (12) 0.341
Tender hepatomegaly 
   Yes 553 (84) 179 (90) 26 (81) 57 (78) 0.085
   No 107 (16)   21 (10)   6 (19) 16 (22%)
Diabetes mellitus
   No 546 (83) 166 (83) 25 (78) 60 (82) 0.925
   Yes 115 (17) 34 (17)   7 (22) 13 (18)
Treatment
   Aspiration not
   done
375 (57) 109 (54) 12 (37) 44 (60) 0.151
   Aspiration done 286 (43)   91 (46) 20 (63) 29 (40)
Patient outcome
   Alive 649 (98) 192 (96) 31 (97) 72 (99)
   Died 12 (2)   8 (4) 1 (3) 1 (1) 0.352
1Fever or abdominal pain.
Table 3  Laboratory features of the patients with liver abscess
Characteristics
(mean ± SD)
Aspiration
group
(n  = 426)
Non aspiration
group
(n  = 540)
Odds
ratio
95% CI P
value
Total bilirubin
(mg/dL) 
2.55 ± 3.4 1.86 ± 2.2 1.090 1.04-1.15 0.001
ALT (IU/L) 81.29 ± 98.87 66.18 ± 75.9 1.002 1.000-1.004 0.010
Alkaline
phosphatase (IU/L) 
18.45 ± 141.3     86.8 ± 117.2 1.002 0.001-1.003 0.001
Albumin (g/L) 2.24 ± 0.50 2.42 ± 0.6 0.590 0.44-0.80 0.001
Serum creatinine
(mg/dL) 
1.37 ± 1.20 1.25 ± 0.8 1.130 0.99-1.28 0.070
Leukocyte counts
(103/mm3) 
  20.09 ± 9.61 18.67 ± 8.03 1.010 1.004-1.030 0.010
Platelet counts
(103/mm3)
357.69 ± 162.40a  328.33 ± 143.98 1.001 1.000-1.002 0.004
Variable compared to reference category (OR = 1), aP < 0.05; ALT: Alanine 
aminotransferase.
Characteristics Aspiration
group
(n  = 426)
Non aspiration
group
(n  = 540)
Odds 
ratio
95% CI P
value
No. of abscess 
Single abscess 303 (71.1) 434 (80.4) 1.00
Multiple abscesses  123 (28.9)a 106 (19.6) 1.66 1.23-2.24 0.001
Site of lobe involvement
   Right lobe 301 (70.7) 415 (76.9) 0.97 0.67-1.40
   Left lobe   59 (13.8)   79 (14.6) 1.00 - 0.010
   Both lobes    66 (15.5)a 46 (8.4) 1.92 1.15-3.18
 Presence of gallstones
   Yes    8 (1.9)a 11 (2.0) 0.92
   No 418 (98.1) 529 (98.0) 1.00 0.36-2.30 0.860
Chest radiograph
   Normal 235 (55.2) 334 (61.9) 1.00
   Abnormal1  191 (44.8)a 206 (38.1) 1.31 1.01-1.70 0.030
Size of abscess
   ≤ 5 cm 121 (28.4) 209 (38.7) 1.00
   > 5 cm  305 (71.6)a 331 (61.3) 1.59 1.21-2.09 0.001
Table 4  Radiological features of patients with liver abscess (%)
1Raised right hemi diaphragm, pleural effusion, and right lung base 
atelactasis. Variable compared to reference category (OR = 1), aP < 0.05.
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most of  these patients respond to antibiotics and 
supportive care, a significant number eventually require 
needle aspiration which is generally done at a later stage, 
while medical therapy alone is considered as inadequate, 
resulting in an extended hospital stay[17-21].
An early decision regarding aspiration of  liver abscess 
is therefore important as it is likely to reduce the length 
of  hospital stay and hence the cost of  treatment. On the 
basis of  patient characteristics at the time of  presentation, 
using a large data set, we have identified some factors that 
are associated with aspiration of  liver abscess irrespective 
of  the underlying etiology but we were unable to evolve a 
model for aspiration with good power.
Most patients in this series also recovered completely 
on appropriate antibiotics and supportive care. However 
in a substantial number of  patients, percutaneous needle 
aspiration was additionally done for complete recovery. 
Based upon a comparative analysis between the two 
groups, patients who underwent aspiration were older, 
had larger or multiple abscesses and longer duration of  
symptoms than patients who recovered completely on 
medical therapy alone. Underlying etiology of  amebic, 
pyogenic, mixed or indeterminate infection was not found 
to be a determinant for aspiration.
This study also reflects the difficulties sometimes faced 
by clinicians in determining the etiology of  liver abscess. 
In this series, 68% of  the 966 patients were diagnosed to 
have ALA, reflecting the burden of  amebic infection in 
tropical regions of  the world[3].
The diagnosis of  ALA is usually based on clinical and 
radiological features along with a positive IHA Entameba 
titer[1-3]. However none of  these features are diagnostic 
and, in clinical practice, confusion can often arise as to the 
accurate diagnosis of  ALA. For example a solitary abscess 
in the right lobe of  the liver is considered to be highly 
suggestive of  ALA[3,6,22], which was true for 79% of  ALA 
patients in this study. However a predominantly single 
abscess involving the right lobe was also seen in 68% of  
patients with PLA, suggesting that the presence of  a single 
right lobe abscess should not exclude the diagnosis of  
PLA even in areas endemic for ALA. Similarly, although 
multiple abscesses involving both lobes were present more 
commonly in patients with PLA[23-25], they were also seen 
in 21% of  patients with ALA.
The IHA Entameba titer is used to confirm the 
diagnosis of  ALA. A high titer of  IHA in invasive 
amebiasis is seen due to prolonged antigenic stimulation 
of  absorbed liver abscess material[2]. However some issues 
should be considered when amoebic IHA is used in clinical 
practice. There is firstly the problem inherent in any 
serological assay, and that is the time lag required for the 
test to become positive so that the first reading may not 
achieve diagnostic values[2]. Secondly, in an endemic area, 
the appropriate cut off  value for a positive test needs to 
be defined, keeping in mind the background positivity due 
to repeated (sub clinical) exposures[1-3]. Titers of  ≥ 1:128 
were considered as diagnostic for ALA in this study, based 
upon the manufacturer’s recommendations and current 
literature[1,2]. However the higher the titer, the better is its 
diagnostic value considered.
Patients with pyogenic liver abscess (PLA) in this study 
has shown some differences in their clinical profile compar-
ed with other reported series; they were younger (mean 
age of  43 ± 17 years) and the etiology was predominantly 
cryptogenic[18,19].
Although gallstones were present more frequently 
in PLA compared to patients with ALA, they were not 
associated with ascending cholangitis in the present 
series as reported previously[15,16]. The reasons for these 
differences are not clear. However other reports also show 
series of  patients with PLA where the primary focus of  
infection was not known[26-28].
Mixed abscess in this series comprised of  32 (3%), 
similar to the 4%-5%. Prevalence reported in the 
literature[20]. Mixed abscesses are basically ALA with 
secondary bacterial infection and their outcome was similar 
to ALA in the current series (Table 5) while in some studies 
mixed abscess has high mortality[29,30].
Patients with indeterminate liver abscess behaved like 
ALA as regards response to treatment and outcome of  
disease. However the IHA titer failed to rise, even on 
successive testing in some cases. This may be due to a 
technical failure of  the serological tests in these patients 
for various reasons, including a depressed immune status.
In conclusion, based upon a retrospective analysis of  a 
large series of  patients, we have found that if  the patient 
with liver abscess is older in age, the abscess is more than 
5 cm in size, both lobes of  the liver are involved and the 
duration of  symptoms is more than a week, then these 
patients are more likely to undergo percutaneous aspiration 
regardless of  the etiology of  abscess.  A prospective study 
to validate these observations is underway, and if  found 
accurate, it is likely to have an impact on cost effective 
approaches and quality of  life in the management of  such 
patients.
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Table 5  Independent predictors for aspiration of liver abscess
Factor Coefficient Adjusted 95% CI for Wald 
odds ratio adjusted odds ratio P -value
Age
   < 55 yr 0 11
   ≥ 55 yr 0.5135   1.6 1.2-2.2 0.001
Size of abscess
   ≤ 5 cm 0 11
   > 5 cm 0.5324   1.6 1.2-2.09 0.001
Location of abscess
   One lobe 0 11
   Both lobes 0.7958   2.2 1.5-3.4 0.001
Duration of symptoms
   < 7 d 0 11
 ≥ 7 d 0.4542   1.6 1.2-2.1 0.001
The parameter coefficient, adjusted odds ratio, 95% CI and Wald P-value, 
were estimated using multiple logistic regression. 1Reference category.
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 COMMENTS
Background
Liver abscess, especially the amebiasis is more prevalent in the tropical region 
of the world due to poor hygiene and sanitation. The standard treatment of 
liver abscess is the use of appropriate antibiotics and supportive care. Needle 
aspiration can be used as an additional mode of therapy and has been promoted 
by some authors for routine use in the treatment of liver abscess. It is suggested 
that needle aspiration can improve responses to antibiotic treatment, reduce 
hospital stay and the total cost of treatment. Needle aspirations, especially at 
the time of intervention has therefore remained a debatable issue and it seems 
important to determine its possible role in the treatment of liver abscess.
Research frontiers 
On the basis of a large dataset, we determine the factors associated with the 
likelihood of liver abscess aspiration in the treatment of patients with uncomplicated 
liver abscess.
Innovations and breakthroughs
Based upon a retrospective analysis of a large series of patients, we have found 
that if the patient with liver abscess is older in age, abscess is more than 5 cm in 
size, both lobes of the liver are involved and duration of symptoms is more than 
a week then these patients are more likely to undergo percutaneous aspiration 
regardless of the etiology of abscess.  
Applications 
A prospective study to validate these observations are underway, and if found 
accurate, it is likely to have an impact on the cost effectiveness and quality of life 
in the management of such patients.
Peer review
This paper by Khan et al reports information on predictive factors for aspiration 
in liver abscess. It is a retrospective study based on a very large series of cases. 
A number of factors showed predictive values for aspiration in liver abscess. 
Although retrospective, this study is well-designed and performed and the findings 
are sound for the clinical arena.
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